Search research articles
Contact Us
Filters
Showing results (251-260 of 393) with videos related to
Page
of 40
Sort By:
Plos One
|
January 21, 2017
High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments
Hsiao-Ching Nien, Shih-Jer Hsu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology
|
July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus
Yu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 21, 2024
Serological responses to COVID-19 vaccination in patients with chronic liver diseases
Yu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, et al.
Oxidative Medicine and Cellular Longevity
|
August 2, 2021
1-Nitropyrene Induced Reactive Oxygen Species-Mediated Apoptosis in Macrophages through AIF Nuclear Translocation and AMPK/Nrf-2/HO-1 Pathway Activation
Chun-Hung Su, Yung-Chuan Ho, Min-Wei Lee, et al.
Hepatology International
|
September 25, 2015
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
Chia-Chi Wang, Chih-Lin Lin, Tsai-Yuan Hsieh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 1, 2015
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
Kuo-Chih Tseng, Chih-Wei Tseng, Tsai-Yuan Hsieh, et al.
The Chinese Journal of Physiology
|
July 3, 2018
Zerumbone from Zingiber zerumbet Ameliorates Lipopolysaccharide-Induced ICAM-1 and Cytokines Expression via p38 MAPK/JNK-IκB/NF-κB Pathway in Mouse Model of Acute Lung Injury
Chien-Ying Lee, Shih-Pin Chen, Chun-Hung Su, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Jeong Heo, Ja-Der Liang, Chang Won Kim, et al.
British Journal of Cancer
|
March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial
Yu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Page
of 40
Search research articles
Search
Showing results (251-260 of 393) with videos related to
Sort By:
Page
of 40
Plos One
|
January 21, 2017
High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments
Hsiao-Ching Nien, Shih-Jer Hsu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology
|
July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virus
Yu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
June 21, 2024
Serological responses to COVID-19 vaccination in patients with chronic liver diseases
Yu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, et al.
Oxidative Medicine and Cellular Longevity
|
August 2, 2021
1-Nitropyrene Induced Reactive Oxygen Species-Mediated Apoptosis in Macrophages through AIF Nuclear Translocation and AMPK/Nrf-2/HO-1 Pathway Activation
Chun-Hung Su, Yung-Chuan Ho, Min-Wei Lee, et al.
Hepatology International
|
September 25, 2015
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
Chia-Chi Wang, Chih-Lin Lin, Tsai-Yuan Hsieh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 1, 2015
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
Kuo-Chih Tseng, Chih-Wei Tseng, Tsai-Yuan Hsieh, et al.
The Chinese Journal of Physiology
|
July 3, 2018
Zerumbone from Zingiber zerumbet Ameliorates Lipopolysaccharide-Induced ICAM-1 and Cytokines Expression via p38 MAPK/JNK-IκB/NF-κB Pathway in Mouse Model of Acute Lung Injury
Chien-Ying Lee, Shih-Pin Chen, Chun-Hung Su, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Jeong Heo, Ja-Der Liang, Chang Won Kim, et al.
British Journal of Cancer
|
March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial
Yu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Page
of 40